Raytheon Faces Dual-Track Setup: War-Driven Surge vs. Structural Capacity Expansion

The investment thesis for Raytheon is now being written in real time. The immediate catalyst is the Iran conflict, which has triggered a massive, direct surge in demand for its weapons. In the first 16 days of the war, more than 500 Tomahawk cruise missiles built at its Tucson plant flew into Iran, a launch estimated to be worth about $1.9 billion. This isn't just a spike in orders; it's a full-scale deployment of a strategic arsenal, with analysts noting that replacing these missiles could take at least five years.

This operational surge has been mirrored on the stock chart. Over the past 52 weeks, RTX stock has surged 66.7%, a performance that significantly outpaces the broader market. The stock recently traded near $203, a level that reflects this wartime premium. The move is part of a broader Pentagon push to accelerate production, effectively putting weapons manufacturing on a wartime footing.

Historically, such concentrated demand is rare. The scale of launching nearly 500 precision-guided missiles in just weeks recalls the initial phases of major conflicts like the Gulf War, where industrial output was rapidly reoriented to meet urgent battlefield needs. Today's demand, however, is more targeted and sustained, driven by a specific regional crisis. The key difference is the speed of the response: the Pentagon is not waiting for a full mobilization order. It is acting now, and Raytheon's production lines are the critical node in that effort.

The Structural Shift: From Backlog to Capacity – A Historical Precedent

The immediate war-driven surge is one thing. The longer-term investment case hinges on a deeper, structural shift in how the Pentagon buys weapons. This is a move from managing a large, existing order backlog to securing multi-year contracts for expanded production capacity-a pattern seen in past arms races.

The blueprint for this shift was laid out in November with the Pentagon's "Acquisition Transformation Strategy". The document's core directive is clear: award "bigger, longer deals" to incentivize industry to invest in growing the weapons manufacturing base. The recent conflict has accelerated this plan, providing a real-world test of its logic.

The key evidence of this new era is the agreement by major defense CEOs, including Raytheon's, to "quadruple production" of key systems like Patriot interceptors and THAAD missiles. This isn't just a promise to work faster on current orders. It's a commitment to build new capacity, a fundamental industrial expansion. The Pentagon's November strategy explicitly calls for this kind of investment, and the White House meeting has now formalized it.

Viewed historically, this is a familiar pivot. In past arms races, like the Cold War buildup, the trigger was often a perceived strategic threat that forced a rapid scaling of industrial output. The difference today is the mechanism. Instead of waiting for a full mobilization order, the government is proactively offering long-term contracts to de-risk that expansion. The goal is to avoid the stockpile depletion that has plagued the U.S. in recent conflicts, ensuring readiness for the next crisis.

For Raytheon, this shift is a powerful tailwind. It moves the company from being a high-margin supplier to a critical partner in national industrial policy. The company's existing backlog provides a stable foundation, but the new multi-year deals for expanded capacity promise a more predictable, longer-duration revenue stream. This structural change, validated by the recent White House agreement, is what transforms a wartime spike into a sustained growth story.

Valuation and the Dual-Track Risk

The stock's 66.7% surge over the past year has priced in a powerful narrative. With a market cap of $264.1 billion, the valuation already embeds significant faith in Raytheon's future growth trajectory. The immediate war-driven demand is a major part of that story, but the critical question for investors is whether the current price reflects durable, structural expansion or is overly reliant on volatile conflict.

Analyst projections for fiscal 2026 show a company growing, but not at the wartime pace. The consensus expects earnings per share to reach $6.81, representing an 8.3% increase from the prior year. This forward view is for a normalized period, not one dominated by a regional war. The upcoming Q1 2026 report, due on April 21, will be a key test. The company has a strong track record of beating estimates, but the bar has been raised by the stock's recent run.

The central risk is a ceasefire. If the Iran conflict ends, the immediate, massive demand for Tomahawks and other systems would vanish. This could expose the stock to a sharp re-rating if the new multi-year production contracts fail to ramp quickly enough to meet the market's elevated expectations. The historical precedent here is instructive: defense stocks often see volatility tied to geopolitical headlines, but the real test is whether industrial expansion can provide a stable floor for earnings.

The bottom line is a dual-track setup. The war provides a powerful near-term catalyst, but the valuation demands that the structural shift toward expanded capacity delivers. The average analyst price target of $214.23 implies about 9% upside, a modest premium that suggests some caution. For the stock to sustain its premium, the new production deals must translate into revenue growth that matches or exceeds the 8.3% EPS projection. The market is betting on the industrial shift; the risk is that the war's end reveals the bet was placed too early.

Catalysts and What to Watch

The dual-track thesis now faces its first real test. The immediate catalyst is the Q1 2026 earnings report, set for release on April 21. This report will be the first to capture the full financial impact of the Iran conflict's opening weeks. Investors will scrutinize the numbers to see how much of the quarter's revenue and profit was driven by the surge in Tomahawk launches and other wartime orders. A strong beat would validate the near-term war premium, while a miss could signal the spike is fading faster than expected.

Beyond the quarterly results, the market will be watching for concrete signals of the structural shift. The key will be announcements of new multi-year contracts following the Pentagon's "Acquisition Transformation Strategy". The White House meeting last month saw defense CEOs agree to "quadruple production" of key systems, but the real test is whether the Pentagon follows through with the "bigger, longer deals" it has promised to de-risk that expansion. Any new contract awards for expanded capacity would be a direct validation of the industrial shift.

Finally, the pace of production ramp-up will be critical. The Pentagon's strategy is to avoid future stockpile depletion, but expanding production lines of complex weapons takes time, years in some cases. The scale of the initial demand is staggering: replacing the 500+ Tomahawk cruise missiles used in the first 16 days of the war could take at least five years. Historical parallels show that industrial mobilization, even under wartime pressure, is a marathon, not a sprint. The market will need to see consistent progress reports on production lines to believe the capacity expansion is on track to meet future demand and support the stock's elevated valuation.